Advanced Life Sciences’ Cethromycin Faces Anti-Infectives Panel With Solid Data

Firm is first of several near-term NDAs for community acquired pneumonia to come before FDA this year amid changing regulatory standards for anti-infective development.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet